These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 22085320

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Myopathy associated with statin therapy.
    Hilton-Jones D.
    Neuromuscul Disord; 2008 Jan; 18(1):97-8. PubMed ID: 17892936
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y, Yamashita S.
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immune Mediated Myopathy following Long-Term Statin Therapy.
    Watad A, Soriano A, Vaknine H, Shoenfeld Y, Amital H.
    Isr Med Assoc J; 2015 Feb; 17(2):128-9. PubMed ID: 26223095
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Intense physical exercise, muscle involvement and statin use].
    Toussirot E, Michel F, Meneveau N.
    Presse Med; 2014 Jun; 43(6 Pt 1):726-7. PubMed ID: 24630267
    [No Abstract] [Full Text] [Related]

  • 11. Statin-associated myopathy.
    Hamilton-Craig I.
    Med J Aust; 2001 Nov 05; 175(9):486-9. PubMed ID: 11758079
    [Abstract] [Full Text] [Related]

  • 12. [HMG-CoA reductase inhibitors (statin)].
    Yamamura T, Ishigami M.
    Nihon Rinsho; 2007 Jul 28; 65 Suppl 7():458-64. PubMed ID: 17824071
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Niacin extended-release therapy in phase III clinical trials is associated with relatively low rates of drug discontinuation due to flushing and treatment-related adverse events: a pooled analysis.
    Brinton EA, Kashyap ML, Vo AN, Thakkar RB, Jiang P, Padley RJ.
    Am J Cardiovasc Drugs; 2011 Jun 01; 11(3):179-87. PubMed ID: 21619381
    [Abstract] [Full Text] [Related]

  • 15. [Ezetimibe: caution in the face of doubt].
    Araujo F, Mateo de Castro J, Encinas Barrios C.
    Farm Hosp; 2010 Jun 01; 34(4):212-4. PubMed ID: 20153227
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Update on statins: 2003.
    Vaughan CJ, Gotto AM.
    Circulation; 2004 Aug 17; 110(7):886-92. PubMed ID: 15313959
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Statin induced myopathy.
    Sathasivam S, Lecky B.
    BMJ; 2008 Nov 06; 337():a2286. PubMed ID: 18988647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.